Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yujin Hoshida

Showing results (41-50 of 263) with videos related to

Pageof 27
Sort By:
Current Hepatology Reports|March 25, 2017
Tailored algorithms for hepatocellular carcinoma surveillance: Is one-size-fits-all strategy outdated?Nicolas Goossens, C Billie Bian, Yujin Hoshida
Hepatology (Baltimore, Md.)|June 18, 2019
Dose and Duration of Aspirin Use to Reduce Incident Hepatocellular CarcinomaNaoto Fujiwara, Amit G Singal, Yujin Hoshida
Expert Review of Gastroenterology & Hepatology|April 9, 2009
Molecular profiling to predict hepatocellular carcinoma outcomeYujin Hoshida, Augusto Villanueva, Josep M Llovet
Hepatology (Baltimore, Md.)|April 15, 2025
Unraveling the genetic susceptibility to HBV-related liver cancer: The role of virus-host immune interactionsPierre Tonnerre, Yujin Hoshida, Thomas F Baumert
Digestive Diseases and Sciences|October 27, 2022
Precision HCC Surveillance: It Is All in the Number (Needed)Amit G Singal, Neehar D Parikh, Yujin Hoshida
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|March 26, 2003
[Study of digestive diseases in post-genome era]Masao Omata, Motoyuki Otsuka, Takayuki Kawakami, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 24, 2020
Omics-derived hepatocellular carcinoma risk biomarkers for precision care of chronic liver diseasesNaoto Fujiwara, Tongqi Qian, Bhuvaneswari Koneru, et al.
EMBO Molecular Medicine|August 5, 2015
Origin and interpretation of cancer transcriptome profiling: the essential role of the stroma in determining prognosis and drug resistanceNicolas Goossens, Yujin Hoshida, Julio A Aguirre-Ghiso
Hepatology (Baltimore, Md.)|May 7, 2014
Reply: To PMID 24677197Bryan C Fuchs, Yujin Hoshida, Kenneth K Tanabe
Journal of Hepatology|October 4, 2011
Genomic risk of hepatitis C-related hepatocellular carcinomaYujin Hoshida, Bryan C Fuchs, Kenneth K Tanabe
Pageof 27

Showing results (41-50 of 263) with videos related to

Sort By:
Pageof 27
Current Hepatology Reports|March 25, 2017
Tailored algorithms for hepatocellular carcinoma surveillance: Is one-size-fits-all strategy outdated?Nicolas Goossens, C Billie Bian, Yujin Hoshida
Hepatology (Baltimore, Md.)|June 18, 2019
Dose and Duration of Aspirin Use to Reduce Incident Hepatocellular CarcinomaNaoto Fujiwara, Amit G Singal, Yujin Hoshida
Expert Review of Gastroenterology & Hepatology|April 9, 2009
Molecular profiling to predict hepatocellular carcinoma outcomeYujin Hoshida, Augusto Villanueva, Josep M Llovet
Hepatology (Baltimore, Md.)|April 15, 2025
Unraveling the genetic susceptibility to HBV-related liver cancer: The role of virus-host immune interactionsPierre Tonnerre, Yujin Hoshida, Thomas F Baumert
Digestive Diseases and Sciences|October 27, 2022
Precision HCC Surveillance: It Is All in the Number (Needed)Amit G Singal, Neehar D Parikh, Yujin Hoshida
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|March 26, 2003
[Study of digestive diseases in post-genome era]Masao Omata, Motoyuki Otsuka, Takayuki Kawakami, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 24, 2020
Omics-derived hepatocellular carcinoma risk biomarkers for precision care of chronic liver diseasesNaoto Fujiwara, Tongqi Qian, Bhuvaneswari Koneru, et al.
EMBO Molecular Medicine|August 5, 2015
Origin and interpretation of cancer transcriptome profiling: the essential role of the stroma in determining prognosis and drug resistanceNicolas Goossens, Yujin Hoshida, Julio A Aguirre-Ghiso
Hepatology (Baltimore, Md.)|May 7, 2014
Reply: To PMID 24677197Bryan C Fuchs, Yujin Hoshida, Kenneth K Tanabe
Journal of Hepatology|October 4, 2011
Genomic risk of hepatitis C-related hepatocellular carcinomaYujin Hoshida, Bryan C Fuchs, Kenneth K Tanabe
Pageof 27